Todd Dollinger

The Trendlines Group establishes, invests in, and develops innovation-based businesses in the medical and agritech fields. We are seed-stage investors, intensely involved in our portfolio companies, all of which are located in our facilities for at least their first two-three years. We invest principally through our incubator platforms in Israel and Singapore. We establish companies at the intersection of unmet market need and inspired innovation. Our mission is to create and develop companies to improve the human condition. Trendlines owns the Trendlines Medical and Trendlines Agtech incubators in Israel and Trendlines Medical Singapore, as well as Trendlines Labs, our in house innovation center. Trendlines starts 8 - 10 new companies annually and has more than 50 companies in its portfolio ranging in age from "brand new" to companies in revenues. We are traded on the Singapore Stock Exchange. Specialties: Trendlines invests in the medical and agritech fields.